Jump to content

Akkermansia muciniphila: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
FrescoBot (talk | contribs)
New section ==Description of Akkermansia muciniphila sp. nov.==
Line 11: Line 11:
}}
}}


'''''Akkermansia muciniphila''''' is a species of human intestinal [[mucin]]-degrading bacterium. It is [[Gram-negative]], strictly anaerobic, non-[[motile]], non-[[spore]]-forming and oval-shaped. Its type strain is Muc<sup>T</sup> (=ATCC BAA-835<sup>T</sup> =CIP 107961<sup>T</sup>).<ref name="Derrien2004">{{cite journal|last1=Derrien|first1=M.|title=Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium|journal=INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY|volume=54|issue=5|year=2004|pages=1469–1476|issn=1466-5026|doi=10.1099/ijs.0.02873-0}}</ref> Extensive research is being undertaken to understand its association with obesity and diabetes.<ref name="EverardBelzer2013">{{cite journal|last1=Everard|first1=A.|last2=Belzer|first2=C.|last3=Geurts|first3=L.|last4=Ouwerkerk|first4=J. P.|last5=Druart|first5=C.|last6=Bindels|first6=L. B.|last7=Guiot|first7=Y.|last8=Derrien|first8=M.|last9=Muccioli|first9=G. G.|last10=Delzenne|first10=N. M.|last11=de Vos|first11=W. M.|last12=Cani|first12=P. D.|title=Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity|journal=Proceedings of the National Academy of Sciences|volume=110|issue=22|year=2013|pages=9066–9071|issn=0027-8424|doi=10.1073/pnas.1219451110}}</ref><ref>Wageningen University and Research Centre (2013, May 15). Intestinal bacterium Akkermansia curbs obesity. ScienceDaily. Retrieved August</ref><ref name=DM>{{cite news|last=REILLY|first=RACHEL|title=Good gut bacteria could provide new treatment for obesity and diabetes |url=http://www.dailymail.co.uk/health/article-2323945/Good-gut-bacteria-provide-new-treatment-obesity-diabetes.html|accessdate=25 August 2013|newspaper=Daily Mail|date=13 May 2013}}</ref>
'''''Akkermansia muciniphila''''' is a species of human intestinal [[mucin]]-degrading bacterium. It is [[Gram-negative]], strictly anaerobic, non-[[motile]], non-[[spore]]-forming and oval-shaped. Its type strain is Muc<sup>T</sup> (=ATCC BAA-835<sup>T</sup> =CIP 107961<sup>T</sup>).<ref name="Derrien2004">{{cite journal|last1=Derrien|first1=M.|title=Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium|journal=INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY|volume=54|issue=5|year=2004|pages=1469–1476|issn=1466-5026|doi=10.1099/ijs.0.02873-0}}</ref> Extensive research is being undertaken to understand its association with obesity and diabetes.<ref name="EverardBelzer2013">{{cite journal|last1=Everard|first1=A.|last2=Belzer|first2=C.|last3=Geurts|first3=L.|last4=Ouwerkerk|first4=J. P.|last5=Druart|first5=C.|last6=Bindels|first6=L. B.|last7=Guiot|first7=Y.|last8=Derrien|first8=M.|last9=Muccioli|first9=G. G.|last10=Delzenne|first10=N. M.|last11=de Vos|first11=W. M.|last12=Cani|first12=P. D.|title=Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity|journal=Proceedings of the National Academy of Sciences|volume=110|issue=22|year=2013|pages=9066–9071|issn=0027-8424|doi=10.1073/pnas.1219451110}}</ref><ref>Wageningen University and Research Centre (2013, May 15). Intestinal bacterium Akkermansia curbs obesity. ScienceDaily. Retrieved August</ref><ref name=DM>{{cite news|last=REILLY|first=RACHEL|title=Good gut bacteria could provide new treatment for obesity and diabetes |url=http://www.dailymail.co.uk/health/article-2323945/Good-gut-bacteria-provide-new-treatment-obesity-diabetes.html|accessdate=25 August 2013|newspaper=Daily Mail|date=13 May 2013}}</ref>

==Description of Akkermansia muciniphila sp. nov.==
<blockquote>
''Akkermansia muciniphila'' (mu.ci.ni'phi.la. N.L. neut. n. ''mucinum'' mucin; Gr. adj. ''philos'' loving; N.L. fem. adj. ''muciniphila'' mucin-loving).<br>

Cells are oval-shaped, non-motile and stain Gram-negative. The long axis of single cells is 0.6–1.0 mm, depending on the substrate used. Cells occur singly, in pairs, in short chains and in aggregates. Growth occurs at 20–40°C and pH 5.5–8.0, with optimum growth at 37°C and pH 6.5. Strictly anaerobic. Able to grow on gastric mucin, brain–heart infusion and Columbia media, and on N-acetylglucosamine, N-acetylgalactosamine and glucose when these three sugars are in the presence of (each at 2 g l<sup>-1</sup>) peptone, yeast extract, casitone and tryptone. Cellobiose, lactose, galactose, xylose, fucose, rhamnose, maltose, succinate, acetate, fumarate, butyrate, lactate, casitone, Casamino acids, tryptone, peptone, yeast extract, proline, glycine, aspartate, serine, threonine and glutamate do not support growth. Capable of using mucin as carbon, energy and nitrogen source. Able to release sulfate in a free form from mucin fermentation. In mucin medium, cells are covered with filaments. Growth occurs without vitamins. Colonies appear white with a diameter of 0.7 mm in soft agar mucin medium.<br>

The type strain is Muc<sup>T</sup> (=ATCC BAA-835<sup>T</sup>=CIP 107961<sup>T</sup>), isolated from the human intestinal tract. Its DNA G+C content is 47.6 mol%.<ref name="Derrien2004"/>{{rp|1474}}
</blockquote>


==References==
==References==

Revision as of 13:34, 29 April 2014

Akkermansia muciniphila
Scientific classification
Kingdom:
Phylum:
Class:
Order:
Family:
Genus:
Species:
A. longus
Binomial name
Akkermansia muciniphila
Derrien et al 2004

Akkermansia muciniphila is a species of human intestinal mucin-degrading bacterium. It is Gram-negative, strictly anaerobic, non-motile, non-spore-forming and oval-shaped. Its type strain is MucT (=ATCC BAA-835T =CIP 107961T).[1] Extensive research is being undertaken to understand its association with obesity and diabetes.[2][3][4]

Description of Akkermansia muciniphila sp. nov.

Akkermansia muciniphila (mu.ci.ni'phi.la. N.L. neut. n. mucinum mucin; Gr. adj. philos loving; N.L. fem. adj. muciniphila mucin-loving).

Cells are oval-shaped, non-motile and stain Gram-negative. The long axis of single cells is 0.6–1.0 mm, depending on the substrate used. Cells occur singly, in pairs, in short chains and in aggregates. Growth occurs at 20–40°C and pH 5.5–8.0, with optimum growth at 37°C and pH 6.5. Strictly anaerobic. Able to grow on gastric mucin, brain–heart infusion and Columbia media, and on N-acetylglucosamine, N-acetylgalactosamine and glucose when these three sugars are in the presence of (each at 2 g l-1) peptone, yeast extract, casitone and tryptone. Cellobiose, lactose, galactose, xylose, fucose, rhamnose, maltose, succinate, acetate, fumarate, butyrate, lactate, casitone, Casamino acids, tryptone, peptone, yeast extract, proline, glycine, aspartate, serine, threonine and glutamate do not support growth. Capable of using mucin as carbon, energy and nitrogen source. Able to release sulfate in a free form from mucin fermentation. In mucin medium, cells are covered with filaments. Growth occurs without vitamins. Colonies appear white with a diameter of 0.7 mm in soft agar mucin medium.

The type strain is MucT (=ATCC BAA-835T=CIP 107961T), isolated from the human intestinal tract. Its DNA G+C content is 47.6 mol%.[1]: 1474 

References

  1. ^ a b Derrien, M. (2004). "Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium". INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 54 (5): 1469–1476. doi:10.1099/ijs.0.02873-0. ISSN 1466-5026.
  2. ^ Everard, A.; Belzer, C.; Geurts, L.; Ouwerkerk, J. P.; Druart, C.; Bindels, L. B.; Guiot, Y.; Derrien, M.; Muccioli, G. G.; Delzenne, N. M.; de Vos, W. M.; Cani, P. D. (2013). "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity". Proceedings of the National Academy of Sciences. 110 (22): 9066–9071. doi:10.1073/pnas.1219451110. ISSN 0027-8424.
  3. ^ Wageningen University and Research Centre (2013, May 15). Intestinal bacterium Akkermansia curbs obesity. ScienceDaily. Retrieved August
  4. ^ REILLY, RACHEL (13 May 2013). "Good gut bacteria could provide new treatment for obesity and diabetes". Daily Mail. Retrieved 25 August 2013.

Further reading